Update your practice as a midwife through this Hybrid professional master’s degree where TECH analyzes the technologies to detect congenital fetal pathologies”

Technological evolution and new therapeutic strategies have led to the development of increasingly sophisticated techniques for the evaluation and monitoring of diseases in both pregnant women and fetuses. Today, health care systems have increasingly powerful ultrasound equipment and more advanced diagnostic tests such as blastocyst biopsy. At the same time, in order to handle all these new tools and the subsequent protocols for their use, professionals must be constantly updated.

This is often difficult to acquire because most educational programs  have a high theoretical load and leave aside the practical applications necessary to exercise this care with greater excellence.
For this reason, TECH offers this program, a pioneer in its type, which combines the teaching process in two fundamental stages. The first phase is entirely theoretical and takes place on a 100% online and interactive platform. From there, the participants of this program will be able to dedicate 1,500 hours to the study of the most recent concepts in this field. They will also use innovative teaching methodologies, such as Relearning and other valuable multimedia materials to facilitate learning.

After completing this first stage, the graduates will carry out a 3-week intensive on-site internship in a prestigious hospital center. During this pedagogical period, they will have the opportunity to apply the knowledge acquired in the theoretical phase in the care of real patients. Additionally, they will work in collaboration with leading experts and will have the opportunity to assimilate directly from their more complex experiences. All this will be possible thanks to the specialized guidance of an adjunct tutor  in charge of providing you with the most modern procedures and methods, who will help you to incorporate them into your daily practice.

In the theoretical stage of this Hybrid professional master’s degree, you will master the key theoretical concepts for the treatment of pathologies in pregnant women”

This Hybrid professional master’s degree in Pregnancy Pathologies for Midwives contains the most complete and up-to-date scientific program on the market. The most important features include:

• Development of more than 100 clinical cases presented by nursing professionals
• The graphic, schematic and eminently practical contents of the courses are designed to provide scientific and assistance information on those medical disciplines that are essential for professional practice
• Presentation of practical workshops on procedures diagnosis, and treatment techniques
• Interactive learning system based on algorithms for decision making on clinical situations
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection
• Furthermore, you will be able to carry out a clinical internship in one of the best medical centers

This TECH program allows you to acquire modern skills for your professional practice in 3 weeks of practical and face-to-face stay”

In this Hybrid professional master’s degree proposal, of a professionalizing nature and blended learning modality, the program is aimed at updating the nursing professionals. The contents are based on the latest scientific evidence, and oriented in a didactic way to integrate theoretical knowledge in nursing practice and allow decision making in patient management.

Thanks to its multimedia content elaborated with the latest educational technology, it will allow the nursing professional to obtain a situated and contextual learning, that is to say, a simulated environment that will provide an immersive learning programmed to train in real situations. The design of this program is focused on Problem-Based Learning, through which you will have to try to solve the different situations of professional practice that arise throughout the program. For this purpose, the student will be assisted by an innovative interactive video system created by renowned experts.

This program and its academic modules offer you a world-class update that will propel your professional results toward excellence"

You will incorporate, in the Internship of this Hybrid Professional Master's program, the latest trends in managing immature labor, protecting mother and baby"

TECH has designed a comprehensive syllabus for this Hybrid professional master’s degree that brings together the latest content on Pregnancy Pathologies for Midwives. The program consists of several academic modules, focused on strategies to manage the mother with Hepatitis or HIV. At the same time, it delves into the latest protocols for successful delivery of an immature fetus. It also examines all the endocrine pathologies of gestational origin that afflict women and the repercussions they can have on the development of their children. On the other hand, these contents are taught from a 100% online study platform, where the materials are accessible 24 hours a day and there are no time restrictions. 

The theoretical part of this program is not subject to pre-established schedules or timetables so that you can schedule your studies according to your personal time and needs”

Module 1. Concept of Gestational Risk, First Trimester Hemorrhage. Congenital Fetal Defects. Prenatal Diagnosis

1.1. Addressing High-risk Pregnancies

1.1.1. Socio-demographic Risk

1.1.1.1. Adolescent Pregnancy. Special considerations
1.1.1.2. Mother with Drug Dependency Problems

1.1.1.2.1. Principles of DrugInduced Teratogenesis
1.1.1.2.2. Alcohol
1.1.1.2.3. Cocaine
1.1.1.2.4. Heroin
1.1.1.2.5. Other drugs: Marijuana, Cannabis

1.1.2. Occupational Risk in Pregnancy. Ergonomics. Radiation Exposure
1.1.3. Risks to Reproductive Health
1.1.4. Current Gestational Risk
1.1.5. Medical Risk

1.2. Miscarriage

1.2.1. Definition and Epidemiology
1.2.2. Main Causes of Miscarriage
1.2.3. Clinical Forms of Abortion

1.2.3.1. Threat of Abortion
1.2.3.2. Abortion in Progress
1.2.3.3. Complete Abortion
1.2.3.4. Incomplete Abortion
1.2.3.5. Deferred Abortion
1.2.3.6. Repeated Abortions: Concept and Approach

1.2.4. Diagnosis

1.2.4.1. Medical History
1.2.4.2. Physical Examination
1.2.4.3. Ultrasound
1.2.4.4. Determination of B-hCG

1.2.5. Treatment of Spontaneous Abortion

1.2.5.1. Medical Treatment
1.2.5.2. Surgical Management

1.2.6. Complications

1.2.6.1. Sepsis or Septic Abortion
1.2.6.2. Hemorrhage and Disseminated Intravascular Coagulation (DIC)

1.2.7. Postabortion Care

1.3. Ectopic or Extrauterine Pregnancy

1.3.1. Definition and Risk Factors
1.3.2. Clinical Symptoms
1.3.3. Clinical and Ultrasound Diagnosis
1.3.4. Types of Extrauterine Gestation: Tubal, Ovarian, Abdominal, etc
1.3.5. Therapeutic Management and Aftercare

1.4. Gestational Trophoblastic Disease

1.4.1. Concept
1.4.2. Clinical forms of Hydatidiform Mole

1.4.2.1. Partial Mole
1.4.2.2. Complete Mole

1.4.3. Clinical forms of Trophoblastic Neoplasia

1.4.3.1. Invasive Mole and Placental Bed Tumor
1.4.3.2. Choriocarcinoma

1.4.4. Clinical and Ultrasound Diagnosis
1.4.5. Treatment
1.4.6. Aftercare and Complications

1.5. Congenital fetal defects due to genetic causes

1.5.1. Types of Chromosome Abnormalities

1.5.1.1. Aneuploidies
1.5.1.2. Structural Abnormalities
1.5.1.3. Sexrelated Disorders

1.5.2. Prenatal Diagnostic Techniques. Inclusion Criteria

1.5.2.1. Invasive Techniques
1.5.2.2. Non-Invasive Techniques

1.5.3. Genetic Counseling

1.6. Congenital Fetal Defects Secondary to Infections: TORCH I

1.6.1. Toxoplasma

1.6.1.1. Etiologic Agent, Clinic and Epidemiology
1.6.1.2. Prevention
1.6.1.3. Diagnosis
1.6.1.4. Treatment
1.6.1.5. Congenital Toxoplasma Infection

1.6.2. Rubella

1.6.2.1. Etiologic Agent, Clinic and Epidemiology
1.6.2.2. Prevention and Vaccination
1.6.2.3. Diagnosis
1.6.2.4. Treatment
1.6.2.5. Congenital rubella infection

1.7. Congenital Fetal Defects Secondary to Infections: TORCH II

1.7.1. Cytomegalovirus

1.7.1.1. Etiologic Agent, Clinic and Epidemiology
1.7.1.2. Prevention
1.7.1.3. Diagnosis
1.7.1.4. Treatment
1.7.1.5. Congenital Cytomegalovirus Infection

1.7.2. Chickenpox

1.7.2.1. Etiologic Agent, Clinic and Epidemiology
1.7.2.2. Prevention and Vaccination
1.7.2.3. Diagnosis
1.7.2.4. Treatment
1.7.2.5. Congenital Chickenpox Infection
1.7.2.6. Complications due to Chickenpox in Mothers

1.8. Congenital Fatal Defects Secondary to Infections: TORCH III

1.8.1. Herpes Simplex Virus

1.8.1.1. Etiologic Agent, Clinic and Epidemiology
1.8.1.2. Prevention
1.8.1.3. Diagnosis
1.8.1.4. Treatment
1.8.1.5. Congenital Herpes Simplex Infection

1.8.2. Syphilis

1.8.2.1. Etiologic Agent, Clinic and Epidemiology
1.8.2.2. Prevention
1.8.2.3. Diagnosis
1.8.2.4. Treatment
1.8.2.5. Sifilis Congenita

1.9. Other Infections that cause Fetal Problems

1.9.1. Parvovirus B19

1.9.1.1. Etiologic Agent, Clinic and Epidemiology
1.9.1.2. Prevention
1.9.1.3. Diagnosis
1.9.1.4. Treatment
1.9.1.5. Congenital parvovirus Infection

1.9.2. Listeria

1.9.2.1. Etiologic Agent, Clinic and Epidemiology
1.9.2.2. Prevention and Vaccination
1.9.2.3. Diagnosis
1.9.2.4. Treatment
1.9.2.5. Congenital Listeria Infection

1.10. HIV and Gestation

1.10.1. Epidemiology
1.10.2. Gestational Screening and Diagnosis
1.10.3. Clinical Management and Treatment
1.10.4. Delivery of an HIV-positive Woman
1.10.5. Neonatal Care and Vertical Infection

Module 2.  Pregnant Woman with Pathology derived from the Digestive System

2.1. Neurovegetative Disorders:

2.1.1. Appetite Disorders
2.1.2. Sialorrhea
2.1.3. Nausea and vomiting

2.2. Hyperemesis Gravidarum

2.2.1. Concept
2.2.2. Etiopathogenesis
2.2.3. Clinical Manifestations
2.2.4. Diagnosis
2.2.5. Treatment and Care

2.3. Mouth Disorders

2.3.1. Cavities During Pregnancy
2.3.2. Epulis Gravidarum
2.3.3. Gingivitis
2.3.4. Perimylolysis
2.3.5. Xerostomia

2.4. Pyrosis and Peptic Ulcers in Pregnant Women

2.4.1. Concept
2.4.2. Effect of Pregnancy on Heartburn and Peptic Ulcers
2.4.3. Treatment and Hygienic Precautions

2.5. Constipation in Pregnancy

2.5.1. Definition: ROMA criteria
2.5.2. Etiology
2.5.3. Diagnosis
2.5.4. Treatment

2.5.4.1. Non-Pharmacological Treatment
2.5.4.2. Medical Treatment

2.6. Inflammatory Bowel Disease

2.6.1. Crohn's Disease

2.6.1.1. Preconception Counseling
2.6.1.2. Impact of Gestation on the Disease
2.6.1.3. Diagnosis during Pregnancy
2.6.1.4. Treatment

2.6.2. Ulcerative Colitis

2.6.2.1. Preconception Counseling
2.6.2.2. Impact of Gestation on the Disease
2.6.2.3. Diagnosis during Pregnancy
2.6.2.4. Treatment

2.7. Appendicitis and Intestinal Obstruction

2.7.1. Acute Appendicitis

2.7.1.1. Concept
2.7.1.2. Special Diagnostic Considerations in Pregnancy
2.7.1.3. Treatment

2.7.2. Intestinal Obstruction

2.7.2.1. Concept
2.7.2.2. Special Diagnostic Considerations in Pregnancy
2.7.2.3. Treatment

2.8. Gallbladder and Liver Pathology

2.8.1. Cholecystitis

2.8.1.1. Special Considerations and Management in Gestation

2.8.2. Colelitiasis

2.8.2.1. Special Considerations and Management in Gestation

2.8.3. Fatty Liver or Acute Hepatic Degeneration:

2.8.3.1. Definition and Aetiology
2.8.3.2. Clinical Symptoms
2.8.3.3. Diagnosis
2.8.3.4. Treatment

2.9. Intrahepatic Cholestasis of Pregnancy

2.9.1. Concept
2.9.2. Clinical Symptoms
2.9.3. Diagnosis
2.9.4. Treatment
2.9.5. Fetal Impact and Prognosis

2.10. Chronic viral hepatitis and Gestation

2.10.1. Hepatitis B

2.10.1.1. Epidemiology
2.10.1.2. Diagnosis and Screening
2.10.1.3. Clinical Management
2.10.1.4. Delivery of an HIV-positive Woman
2.10.1.5. Neonatal Care and Vertical Infection

2.10.2. Hepatitis C:

2.10.2.1. Epidemiology
2.10.2.2. Diagnosis and Screening
2.10.2.3. Clinical Management
2.10.2.4. Delivery of an HIV-positive Woman
2.10.2.5. Neonatal Care and Vertical Infection

2.11. Pancreas

2.11.1. Acute Pancreatitis in Pregnancy
2.11.1.1. Definition and Risk Factors
2.11.1.2. Clinical Symptoms
2.11.1.3. Treatment

Module 3. Pregnant with Hematological and Cardiac Problems

3.1. Gestational Anemia

3.1.1. Concept
3.1.2. Etiopathogenesis and  the Effect on the Fetus
3.1.3. Types of Anemias

3.1.3.1. Microcytic Anemia
3.1.3.2. Normocytic Anemia
3.1.3.3. Macrocytic Anemia

3.1.4. Treatment and Prophylaxis
3.1.5. Other Forms of Anemia

3.1.5.1. Falciform or Sickle Cell Anemia
3.1.5.2. Thalassemia

3.2. Thrombocytopenia

3.2.1. Essential Trombopenia in Pegnancy

3.2.1.1. Causes and Incidence
3.2.1.2. Diagnosis
3.2.1.3. Obstetric Behavior

3.2.2. Idiopathic Thrombocytopenic Purpura

3.2.2.1. Causes and Incidence
3.2.2.2. Diagnosis
3.2.2.3. Obstetric Behavior

3.2.3. Alloimmune Neonatal Thrombopenia

3.2.3.1. Causes and Incidence
3.2.3.2. Diagnosis
3.2.3.3. Obstetric Behavior

3.2.4. Thrombopenia Associated with Hypertensive States of Pregnancy
3.2.5. Therapeutic Management of Thrombopenias in Pregnancy
3.2.6. Therapeutic Management of the Newborn of a Mother with Thrombopenia

3.3. Coagulation Problems

3.3.1. Von Willebrand Disease

3.3.1.1. Definition and Epidemiology
3.3.1.2. Considerations in Childbirth

3.3.2. Hemophilia

3.3.2.1. Definition and Epidemiology
3.3.2.2. Types

3.3.2.2.1. Hemophilia A
3.3.2.2.2. Hemophilia B

3.3.2.3. Chromosomal Inheritance Patterns of Hemophilia
3.3.2.4. Considerations in Childbirth

3.4. Varicose Syndrome

3.4.1. Definition and Pathophysiology
3.4.2. Clinical Symptoms
3.4.3. Diagnosis
3.4.4. Hemorrhoids
3.4.5. Vulvar Varicose Veins

3.5. Perinatal Hemolytic Disease

3.5.1. Concept
3.5.2. Pathophysiology
3.5.3. Rh Isoimmunization
3.5.4. ABO Isoimmunization

3.6. Thromboembolic Disease in Pregnancy and Puerperium: Deep vein Thrombosis and Pulmonary Thromboembolism

3.6.1. Aetiopathogenesis and Risk Factors
3.6.2. Treatment

3.7. Gestational Heart Disease. Cardiac Exploration in Pregnancy

3.7.1. Cardiac Modification in Pregnancy
3.7.2. Epidemiology of Cardiac Pathology in Pregnancy
3.7.3. Risk Classification of Gestational Heart Disease
3.7.4. Preconception Counseling for Pregnant Women with Heart Disease
3.7.5. Situations that Hinder Gestation
3.7.6. Management and Choice of Delivery Method

3.8. Pregnant Women with Valvular Heart Disease

3.8.1. Mitral Senosis
3.8.2. Aortic Stenosis
3.8.3. Mitral Insufficiency
3.8.4. Aortic Insufficiency
3.8.5. Tricuspid Regurgitation
3.8.6. Valve Prosthesis

3.9. Arrhythmias in Pregnancy

3.9.1. Paroxysmal Supraventricular Tachycardia
3.9.2. Atrial Fibrillation
3.9.3. Ventricular Arrhythmias
3.9.4. Bradyarrhythmias

3.10. Pregnant Women with Congenital Cardiac Pathology

3.10.1. Tetralogy of Fallot
3.10.2. Coarctation of Aorta
3.10.3. Marfan Syndrome
3.10.4. Single Ventricle
3.10.5. Fontan
3.10.6. Pregnant Women with Cardiac Transplants

Module 4. Pregnant with neurological, musculoskeletal, dermatological and autoimmune problems

4.1. Epilepsy

4.1.1. Management and Treatment Compatible with Gestation: Preconception Counseling
4.1.2. Effects of Epilepsy on Pregnancy
4.1.3. Effects of Pregnancy on Epilepsy
4.1.4. Crisis Management during Childbirth
4.1.5. Newborns of Epileptic Mothers: Malformations and Congenital Anomalies

4.2. Multiple Sclerosis (MS)

4.2.1. Effects of MS on Pregnancy
4.2.2. Effects of Pregnancy on MS
4.2.3. Clinical Management during Gestation and Pharmacotherapy
4.2.4. Clinical Management during Labor
4.2.5. The Postpartum Period in Women with Multiple Sclerosis

4.3. Peripheral Neuropathies

4.3.1. Carpal Tunnel Syndrome
4.3.2. Radiculopathies: Lumbalgias and Sciatalgias
4.3.3. Herniated Disc
4.3.4. Bell’s Palsy
4.3.5. Meralgia Paresthetica
4.3.6. Cyphoscoliosis

4.4. Spinal Cord Injuries

4.4.1. Clinical Management of Women with a Spinal Cord Injury during Pregnancy
4.4.2. Clinical Management during Labor. Epidural Analgesia
4.4.3. Specific Considerations during the Postpartum Period

4.5. Other Neurological Pathologies present during Gestation

4.5.1. Migraine and headaches
4.5.2. Guillén-Barré Syndrome
4.5.3. Myasthenia Gravis
4.5.4. Cerebrovascular Diseases
4.5.5. Brain Neoplasms

4.6. Dermatological Problems during Pregnancy

4.6.1. Dermatological Changes during Pregnancy

4.6.1.1. Stretch Marks
4.6.1.2. Hyperpigmentation of Pregnancy: Melasma Gravidarum and Nevus

4.6.2. Vascular Changes

4.6.2.1. Spider Veins
4.6.2.2. Palmar Erythema
4.6.2.3. Haemangiomas

4.7. Specific Dermatopathologies of Pregnancy

4.7.1. Herpes Gestationis

4.7.1.1. Clinical Symptoms
4.7.1.2. Diagnosis
4.7.1.3. Differential Diagnosis
4.7.1.4. Prognosis
4.7.1.5. Treatment

4.7.2. Impetigo Herpetiformis

4.7.2.1. Clinical Symptoms
4.7.2.2. Diagnosis
4.7.2.3. Differential Diagnosis
4.7.2.4. Prognosis
4.7.2.5. Treatment

4.7.3. Gestational Prurigo

4.7.3.1. Clinical Symptoms
4.7.3.2. Diagnosis
4.7.3.3. Differential Diagnosis
4.7.3.4. Prognosis
4.7.3.5. Treatment

4.7.4. Papular Dermatosis of Pregnancy

4.7.4.1. Clinical Symptoms
4.7.4.2. Diagnosis
4.7.4.3. Differential Diagnosis
4.7.4.4. Prognosis
4.7.4.5. Treatment

4.7.5. Polymorphous Rash in Pregnancy

4.7.5.1. Clinical Symptoms
4.7.5.2. Diagnosis
4.7.5.3. Differential Diagnosis
4.7.5.4. Prognosis
4.7.5.5. Treatment

4.8. Systemic Lupus Erythematosus and Pregnancy

4.8.1. Preconception Check-up
4.8.2. Check-ups during Gestation

4.8.2.1. First Trimester
4.8.2.2. Second Trimester
4.8.2.3. Third Trimester

4.8.3. Childbirth and Postpartum

4.9. Antiphospholipid Syndrome (APS)

4.9.1. Concept
4.9.2. Pregestational Monitoring of Women with APS
4.9.3. Pregestational Monitoring of Women with APS
4.9.4. Treatment
4.9.5. Childbirth and Postpartum

4.10. Rheumatoid Arthritis

4.10.1. Concept
4.10.2. How Rheumatoid Arthritis affects Gestation
4.10.3. How Gestation affects Rheumatoid Arthritis
4.10.4. Treatment

Module 5. Pregnant with Respiratory and Urological/Renal Problems. Tropical and Subtropical Diseases

5.1. Bronquial Asthma

5.1.1. Concept
5.1.2. Bronchial Asthma during Gestation
5.1.3. Treatment
5.1.4. Asthmatic Crisis and Clinical Management
5.1.5. Considerations in the Delivery of a Pregnant Woman with Bronchial Asthma

5.2. Community-acquired Pneumonia and Aspiration Pneumonia

5.2.1. Etiology
5.2.2. Treatment
5.2.3. Specific Factors during Gestation
5.2.4. Newborn from a Mother with Pneumonia

5.3. Influenza

5.3.1. Etiology
5.3.2. Prevention
5.3.3. Pregnancy Issues
5.3.4. Treatment
5.3.5. Criteria for Hospitalization
5.3.6. Newborn from a Mother with Influenza

5.4. Asymptomatic Bacteriuria

5.4.1. Concept
5.4.2. Etiology
5.4.3. Diagnostic Criteria
5.4.4. Treatment

5.5. Acute Cystitis and Urethral Syndrome

5.5.1. Concept
5.5.2. Etiology
5.5.3. Diagnostic Criteria
5.5.4. Treatment
5.5.5. Monitoring

5.6. Acute Pyelonephritis

5.6.1. Concept
5.6.2. Clinical Symptoms
5.6.3. Diagnosis
5.6.4. Treatment
5.6.5. Admission and Discharge Criteria
5.6.6. Complications

5.7. Obstructive Uropathy

5.7.1. Concept
5.7.2. Clinical Symptoms
5.7.3. Exploration and Specialized Tests
5.7.4. Diagnosis
5.7.5. Treatment
5.7.6. Complications

5.8. Renal Transplantation and Gestation

5.8.1. Effects of Transplantation on Pregnancy
5.8.2. Effects of Pregnancy on Transplants
5.8.3. Considerations during Labor, Postpartum and Lactation

5.9. Tropical and Subtropical Diseases I

5.9.1. Zika

5.9.1.1. Epidemiology
5.9.1.2. Transmission
5.9.1.3. Clinical Symptoms
5.9.1.4. Diagnosis
5.9.1.5. Effects on the Fetus and Congenital Zika Infection
5.9.1.6. Treatment and Prevention

5.9.2. Ebola

5.9.2.1. Epidemiology
5.9.2.2. Transmission
5.9.2.3. Clinical Symptoms
5.9.2.4. Diagnosis
5.9.2.5. Effects on the Fetus
5.9.2.6. Treatment and Prevention

5.9.3. Chagas Disease

5.9.3.1. Epidemiology
5.9.3.2. Transmission
5.9.3.3. Clinical Symptoms
5.9.3.4. Diagnosis
5.9.3.5. Effects on the Fetus
5.9.3.6. Treatment and Prevention

5.10. Tropical and Subtropical Diseases II

5.10.1. Dengue

5.10.1.1. Epidemiology
5.10.1.2.Transmisión
5.10.1.3. Clinical Symptoms
5.10.1.4. Diagnosis
5.10.1.5. Effects on the Fetus
5.10.1.6. Treatment and Prevention

5.10.2. Malaria

5.10.2.1. Epidemiology
5.10.2.2. Transmission
5.10.2.3. Clinical Symptoms
5.10.2.4. Diagnosis
5.10.2.5. Effects on the Fetus
5.10.2.6. Treatment and Prevention

5.10.3. Chikungunya

5.10.3.1. Epidemiology
5.10.3.2. Transmission
5.10.3.3. Clinical Symptoms
5.10.3.4. Diagnosis
5.10.3.5. Effects on the Fetus
5.10.3.6. Treatment and Prevention

Module 6. Pathology of Fetal Growth and Gestational Duration. Premature Labor and Multiple Gestation. Pulmonary and Neurological Maturity

6.1. Intrauterine Growth Restriction (IGR)

6.1.1. Concept
6.1.2. Pathogenesis and Etiological Factors
6.1.3. Prediction
6.1.4. Diagnosis and Classification
6.1.5. Differential Diagnosis of Small Fetus for Gestational Age (SGAF)
6.1.6. Treatment and Completion of the Gestation

6.2. Fetal Macrosomia

6.2.1. Concept
6.2.2. Risk Factors
6.2.3. Obstetric Follow-up and Control
6.2.4. Completion of Gestation
6.2.5. Maternal and Fetal Complications

6.3. Chronologically Prolonged Gestation

6.3.1. Concept
6.3.2. Etiology and Prevention
6.3.3. Fetal Complications
6.3.4. Obstetric Behavior
6.3.5. Induction in Week 41 Vs. Week 42

6.4. Premature birth

6.4.1. Threat of Premature Delivery

6.4.1.1. Definition and Risk Factors
6.4.1.2. Diagnosis:  Ultrasound and Fibronectin test
6.4.1.3. Obstetric Management and Tocolytic Treatment

6.4.2. Delivery Method in Premature Fetus and Specific Considerations

6.5. Cervical Incompetence and Cerclage

6.5.1. Definition of Cervical Incompetence
6.5.2. Signs of Cervical Cerclage
6.5.3. Cerclage Techniques
6.5.4. Pre- and Post-cerclage Considerations
6.5.5. Complications
6.5.6. Cerclage Removal

6.6. Suspected Chorioamnionitis and Clinical Chorioamnionitis

6.6.1. Definition of Chorioamnionitis
6.6.2. Criteria for Suspecting Chorioamnionitis
6.6.3. Diagnosis
6.6.4. Treatment
6.6.5. Specific Considerations in Childbirth

6.7. Multiple Pregnancy

6.7.1. Concept and Classification
6.7.2. Fetal and Maternal Complications
6.7.3. Diagnosis and Determination of Chorionicity
6.7.4. Prenatal Diagnosis and Screening of Chromosomopathies
6.7.5. Gestational Screening
6.7.6. End of Gestation and Delivery Route

6.8. Feto-Fetal Transfusion Syndrome

6.8.1. Definition and Pathophysiology
6.8.2. Diagnostic Criteria
6.8.3. Differential Diagnosis
6.8.4. Treatment

6.8.4.1. Technique of Laser Photocoagulation of Vascular Communications
6.8.4.2. Subsequent monitoring

6.9. Corticosteroid Therapy to Accelerate Fetal Lung Maturation

6.9.1. Concept
6.9.2. Indications
6.9.3. Contraindications
6.9.4. Dosages
6.9.5. Specific Factors according to Gestational Age
6.9.6. Special Situations

6.10. Magnesium Sulfate as a Fetal Neuroprotector

6.10.1. Concept
6.10.2. Indications
6.10.3. Contraindications
6.10.4. Drug Administration and Monitoring
6.10.5. Concomitant use of Tocolytics in suspected Preterm Labor
6.10.6. Side Effects

Module 7. Pathology of the Placenta and Fetal Appendages. Obstetric Accidents

7.1. Placenta Accrete

7.1.1. Definition and Forms of Placenta Accrete

7.1.1.1. Placenta Accreta
7.1.1.2. Placenta Increta
7.1.1.3. Placenta Percreta

7.1.2. Risk Factors
7.1.3. Morbimortality
7.1.4. Diagnosis
7.1.5. Clinical Management and Delivery of Pregnant Women with Placental Accreta

7.2. Placenta Previa

7.2.1. Concept
7.2.2. Classification
7.2.3. Risk Factors
7.2.4. Morbimortality
7.2.5. Diagnosis
7.2.6. Management of gestation and delivery of the pregnant woman with placenta previa

7.3. Placental Morphological and Functional Abnormalities

7.3.1. Size Alterations
7.3.2. Morphological Changes

7.3.2.1. Bilobed Placenta
7.3.2.2. Circumvallate Placenta
7.3.2.3. Placenta Succenturiata
7.3.2.4. Espuria

7.3.3. Placental Insufficiency

7.4. Umbilical Cord Anomalies

7.4.1. Variants of Umbilical Cord Length and its Complications: Knots
7.4.2. Umbilical Cord Anomalies in relation to Appearance

7.4.2.1. Procubitus
7.4.2.2. Laterocidence
7.4.2.3. Prolapses

7.4.2.3.1. Causes
7.4.2.3.2. Action to be taken in case of Cord Prolapse

7.4.3. Placental Insertion Abnormalities

7.4.3.1. Velamentous Insertion
7.4.3.2. Marginal Insertion
7.4.3.3. Previous Vasa

7.4.4. Vascular Anomalies

7.4.4.1. Thrombosis
7.4.4.2. Hematomas
7.4.4.3. The Single Umbilical Artery

7.5. Alterations of the Amniotic Membranes

7.5.1. Amnion Nodosum
7.5.2. Amniotic Bands
7.5.3. Extramembranous Pregnancy
7.5.4. Premature Rupture of Membranes and Chorioamnionitis

7.6. Abnormalities of amniotic fluid

7.6.1. Default: Oligohydramnios and Anhydramnios

7.6.1.1. Concept and Epidemiology
7.6.1.2. Etiological Factors
7.6.1.3. Diagnosis
7.6.1.4. Effects on the Fetus and Neonate
7.6.1.5. Clinical Management and Treatment

7.6.2. In Excess: Polyhydramnios

7.6.2.1. Concept and Epidemiology
7.6.2.2. Etiological Factors
7.6.2.3. Diagnosis
7.6.2.4. Effects on the Fetus and Neonate
7.6.2.5. Clinical Management and Treatment. Delivery Assistance

7.7. Uterine Rupture

7.7.1. Concept
7.7.2. Types
7.7.3. Risk Factors
7.7.4. Clinical Diagnosis
7.7.5. Treatment

7.8. Premature Detachment of a Normally Positioned Placenta

7.8.1. Concept
7.8.2. Risk Factors
7.8.3. Clinical Diagnosis
7.8.4. Clinical Management

7.9. Amniotic Fluid Embolism

7.9.1. Concept
7.9.2. Risk Factors
7.9.3. Pathophysiology
7.9.4. Clinical Symptoms
7.9.5. Diagnosis and Treatment

7.10. Shoulder Dystocia

7.10.1. Concept
7.10.2. Risk Factors
7.10.3. Diagnosis
7.10.4. Delivery Method case of Placental Abruption

7.10.4.1. Primary Level Techniques
7.10.4.2. Secondary Level Techniques
7.10.4.3. Tertiary Level Techniques

7.10.5. Postnatal Care and Assessment

Module 8. Variations in Normal Delivery and the Onset of Labor. Mother Carrying Group B Streptococcus B

8.1. Instrumental Delivery

8.1.1. Concept
8.1.2. Indications
8.1.3. Contraindications
8.1.4. Criteria for using the Different Instruments

8.1.4.1. Forceps
8.1.4.2. Thierry Spatulas
8.1.4.3. Cupping

8.2. Breech Delivery

8.2.1. Concept
8.2.2. Classification
8.2.3. Etiology
8.2.4. Diagnosis
8.2.5. Vaginal Delivery Criteria and Management

8.3. Vaginal Delivery after Cesarean Section

8.3.1. Choice of Delivery Route
8.3.2. Contraindications for Vaginal Delivery with Previous Cesarean Section
8.3.3. Planned Cesarean
8.3.4. Labor Induction

8.4. Cervical Ripening and Induction of Labor

8.4.1. Concept
8.4.2. Indications
8.4.3. Contraindications
8.4.4. Risks from Induction
8.4.5. Methods to Labor

8.5. Fetal Hydrops

8.5.1. Concept

8.5.1.1. Immune Hydrops
8.5.1.2. Non-Immune Hydrops

8.5.2. Pathophysiology
8.5.3. Diagnosis
8.5.4. Clinical Management

8.6. Mother Carrying Group B Streptococcus B(SGB)

8.6.1. Concept
8.6.2. Sample Collecting and Screening
8.6.3. Treatment
8.6.4. Management of Newborns of Mothers who are Carriers of GBS

8.7. Cesarean Section

8.7.1. Indications
8.7.2. Classification
8.7.3. Cesarean Section Contraindications
8.7.4. Surgical Technique
8.7.5. Post-Operative Care

8.8. External Cephalic Version

8.8.1. Concept
8.8.2. Indications
8.8.3. Contraindications
8.8.4. Complete Technique and Procedure
8.8.5. Complications

8.8.5.1. Pharmacological Methods
8.8.5.2. Non-Pharmacological Methods

8.9. Premature Rupture of Membranes

8.9.1. Etiology
8.9.2. Diagnosis
8.9.3. Preterm Premature Rupture of Membranes
8.9.4. Full-term Premature Rupture of Membranes

8.10. Obstetric Anal Sphincter Injuries

8.10.1. Prevention
8.10.2. Classification

8.10.2.1. Third Degree Tear
8.10.2.2. Fourth Degree Tear

8.10.3. Reparation of Perineal Tears
8.10.4. Follow-up and Delivery after Anal Sphincter Injury

Module 9. Endocrine Problems during Pregnancy. Gynecologic Cancer and Pregnancy. Hypertensive States of Pregnancy

9.1. Thyroid Pathology and Gestation

9.1.1. Hypothyroidism

9.1.1.1. Diagnosis
9.1.1.2. Clinical Symptoms
9.1.1.3. Etiology
9.1.1.4. Clinical Management

9.1.2. Hyperthyroidism and Thyrotoxicosis

9.1.2.1. Diagnosis
9.1.2.2. Clinical Symptoms
9.1.2.3. Etiology
9.1.2.4. Clinical Management

9.1.3. Treatment during Gestation
9.1.4. Effects on the Fetus

9.2. Diabetes Mellitus and Pregnancy

9.2.1. Pregestational Management

9.2.2. Gestational Screening
9.2.3. Criteria for the Termination of Pregnancy
9.2.4. Considerations During Childbirth
9.2.5. Newborn from a Mother with Diabetes Mellitus

9.3. Gestational Diabetes

9.3.1. Concept
9.3.2. Risk Factors
9.3.3. Diagnosis and Screening Protocol
9.3.4. Gestational Screening
9.3.5. Criteria for the Termination of Pregnancy
9.3.6. Clinical Management during Labor and Post-partum
9.3.7. Newborn from a Mother with Gestational Diabetes

9.4. Obesity and Pregnancy

9.4.1. Definition and Classification of Obesity
9.4.2. Impact of Obesity on Gestation
9.4.3. Impact of Gestation on Obesity
9.4.4. Obese Women and the Postpartum Period

9.5. Breast Cancer and Pregnancy

9.5.1. Concept and Epidemiology
9.5.2. Diagnosis
9.5.3. Treatment
9.5.4. Prognosis

9.6. Cervical Cancer and Pregnancy

9.6.1. Concept and Epidemiology
9.6.2. Cytology in Gestation
9.6.3. Colposcopy in Gestation
9.6.4. Diagnosis and Treatment

9.7. Ovarian Cancer and Pregnancy

9.7.1. Concept and Epidemiology
9.7.2. Clinical Symptoms
9.7.3. Diagnosis
9.7.4. Treatment

9.8. Hypertensive States of Pregnancy  I

9.8.1. Concept
9.8.2. Classification of Hypertension in Pregnancy
9.8.3. Determination of the Degree of Severity
9.8.4. Prediction and Prevention
9.8.5. Treatment and Clinical Management
9.8.6. Criteria for the Termination of Pregnancy

9.9. Hypertensive states of Pregnancy  II

9.9.1. Eclampsia

9.9.1.1. Diagnosis
9.9.1.2. Clinical Management and Treatment

9.9.2. Hellp's Syndrome

9.9.2.1. Diagnosis
9.9.2.2. Clinical Management and Treatment

9.9.3. Subsequent Follow-up of Pregnant Women with Hypertension Problems

9.10. Antepartum Fetal Death

9.10.1. Concept
9.10.2. Classification
9.10.3. Etiological Factors
9.10.4. Diagnosis
9.10.5. Clinical and Psychological Management
9.10.6. Follow-up Genetic Counseling

Module 10. Pathology of the Postpartum Period. Psychological Issues during the Postpartum Period. Cardiopulmonary Resuscitation in Pregnant Women and Neonates. Legal Termination of Pregnancy

10.1. Postpartum Infection

10.1.1. Concept and Etiology
10.1.2. Risk Factors
10.1.3. Forms of Propagation
10.1.4. Clinical Forms
10.1.5. Clinical Symptoms
10.1.6. Treatment and Prophylaxis

10.2. Postpartum Hemorrhage

10.2.1. Concept
10.2.2. Etiology

10.2.2.1. Uterine Tone
10.2.2.2. Obstetric Trauma and Uterine Inversion
10.2.2.3. Fabric
10.2.2.4. Coagulation Problems

10.2.3. Treatment

10.3. Main Problems in Breastfeeding I

10.3.1. Cracked Nipples
10.3.2. Mammary Ingurgitation and Obstruction
10.3.3. Eczema and Candidiasis of the Nipple
10.3.4. Hypogalactia

10.4. Main Problems in Breastfeeding II

10.4.1. Acute Mastitis

10.4.1.1. Definition, Etiology and Clinical Manifestations
10.4.1.2. Prevention
10.4.1.3. Treatment
10.4.1.4. Complications

10.5. Psychological Issues during the Postpartum Period

10.5.1. Maternity Blues or Postpartum Depression
10.5.2. Postpartum Depression

10.5.2.1. Concept
10.5.2.2. Risk Factors
10.5.2.3. Prevention
10.5.2.4. Treatment

10.5.3. Puerperal Psychosis

10.5.3.1. Concept
10.5.3.2. Risk Factors
10.5.3.3. Prevention
10.5.3.4. Treatment

10.6. Perinatal Bereavement

10.6.1. Concept
10.6.2. Clinical Manifestations
10.6.3. Types of Grief
10.6.4. Phases of Perinatal Bereavement
10.6.5. Psychological Handling

10.7. Postdural Puncture Headache

10.7.1. Concept
10.7.2. Differential Diagnosis
10.7.3. Treatment and Prophylaxis
10.7.4. Complications

10.8. Cardiopulmonary Resuscitation in Pregnant Women

10.8.1. Main Causes of Cardio-Respiratory Arrest in Pregnant Women
10.8.2. Algorithm for Cardiopulmonary Resuscitation
10.8.3. Pregnancy-specific Considerations
10.8.4. Fetal Extraction

10.9. Neonatal Cardiopulmonary Resuscitation

10.9.1. Main Causes of Cardio-Respiratory Arrest in Neonates
10.9.2. Algorithm for Cardiopulmonary Resuscitation
10.9.3. Neuroprotection and Hypothermia in Infants

10.9.3.1. Definition and Mechanism of Action of Hypothermia
10.9.3.2. Inclusion and Exclusion Criteria
10.9.3.3. Treatment Phases and Cooling
10.9.3.4. Limitation of Therapeutic Exercise in Newborns with Hypoxic-Ischemic Encephalopathy

10.10. Legal Termination of Pregnancy

10.10.1. Concept
10.10.2. Legislative Framework
10.10.3. Methods Dependent on the Number of Weeks of Gestation
10.10.4. Feticide

This Hybrid professional master’s degree includes a varied number of educational modules that you can access from any device connected to the Internet, 24 hours a day”